NCT05389319: A Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine Booster in Healthy Adults |
|
|
| Suspended | 1 | 60 | Europe | Prime-2-CoV_Beta | University Hospital Tuebingen, FGK Clinical Research GmbH, VisMederi srl, Staburo GmbH, Viedoc Technologies AB | COVID-19 | 01/25 | 12/25 | | |